Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.05−0.01 (-0.06%)
Close on Nov 18, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Tandem Diabetes Care's revenue for the twelve months ending Jun 30, 2026 was $1.04B, up 4.0% year over year. For fiscal 2025 it was $1.01B, up 7.9% from the year before. Over ten years it grew 30.1% a year on average. The highest annual figure on record is $1.01B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | +7.9% |
| FY2024 | Dec 31, 2024 | $940.20M | +25.7% |
| FY2023 | Dec 31, 2023 | $747.72M | -6.7% |
| FY2022 | Dec 31, 2022 | $801.22M | +14.0% |
| FY2021 | Dec 31, 2021 | $702.80M | +40.9% |
| FY2020 | Dec 31, 2020 | $498.83M | +37.7% |
| FY2019 | Dec 31, 2019 | $362.31M | +97.0% |
| FY2018 | Dec 31, 2018 | $183.87M | +70.9% |
| FY2017 | Dec 31, 2017 | $107.60M | +27.7% |
| FY2016 | Dec 31, 2016 | $84.25M | +15.6% |
| FY2015 | Dec 31, 2015 | $72.85M | +46.5% |
| FY2014 | Dec 31, 2014 | $49.72M | +71.4% |
| FY2013 | Dec 31, 2013 | $29.01M | +1072.0% |
| FY2012 | Dec 31, 2012 | $2.48M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $254.56M | +5.8% |
| Q1 FY2026 | Mar 31, 2026 | $247.22M | +5.5% |
| Q4 FY2025 | Dec 31, 2025 | $290.38M | +2.7% |
| Q3 FY2025 | Sep 30, 2025 | $249.25M | +2.2% |
| Q2 FY2025 | Jun 30, 2025 | $240.68M | +8.5% |
| Q1 FY2025 | Mar 31, 2025 | $234.42M | +22.3% |
| Q4 FY2024 | Dec 31, 2024 | $282.65M | +43.6% |
| Q3 FY2024 | Sep 30, 2024 | $243.97M | +31.4% |
| Q2 FY2024 | Jun 30, 2024 | $221.91M | +13.3% |
| Q1 FY2024 | Mar 31, 2024 | $191.67M | +13.2% |
| Q4 FY2023 | Dec 31, 2023 | $196.80M | -10.8% |
| Q3 FY2023 | Sep 30, 2023 | $185.62M | -9.3% |
| Q2 FY2023 | Jun 30, 2023 | $195.92M | -2.2% |
| Q1 FY2023 | Mar 31, 2023 | $169.38M | -3.7% |
| Q4 FY2022 | Dec 31, 2022 | $220.50M | +5.0% |
| Q3 FY2022 | Sep 30, 2022 | $204.55M | +13.9% |
| Q2 FY2022 | Jun 30, 2022 | $200.26M | +16.3% |
| Q1 FY2022 | Mar 31, 2022 | $175.91M | +24.7% |
| Q4 FY2021 | Dec 31, 2021 | $210.00M | +24.9% |
| Q3 FY2021 | Sep 30, 2021 | $179.63M | +45.3% |
| Q2 FY2021 | Jun 30, 2021 | $172.14M | +57.6% |
| Q1 FY2021 | Mar 31, 2021 | $141.04M | +44.0% |
| Q4 FY2020 | Dec 31, 2020 | $168.07M | +55.0% |
| Q3 FY2020 | Sep 30, 2020 | $123.60M | +30.6% |
| Q2 FY2020 | Jun 30, 2020 | $109.24M | +17.1% |
| Q1 FY2020 | Mar 31, 2020 | $97.93M | +48.4% |
| Q4 FY2019 | Dec 31, 2019 | $108.40M | +42.3% |
| Q3 FY2019 | Sep 30, 2019 | $94.66M | +104.6% |
| Q2 FY2019 | Jun 30, 2019 | $93.26M | +173.3% |
| Q1 FY2019 | Mar 31, 2019 | $66.00M | +141.9% |
| Q4 FY2018 | Dec 31, 2018 | $76.20M | +89.1% |
| Q3 FY2018 | Sep 30, 2018 | $46.26M | +71.3% |
| Q2 FY2018 | Jun 30, 2018 | $34.13M | +60.0% |
| Q1 FY2018 | Mar 31, 2018 | $27.28M | +43.7% |
| Q4 FY2017 | Dec 31, 2017 | $40.29M | +39.4% |
| Q3 FY2017 | Sep 30, 2017 | $27.00M | +119.7% |
| Q2 FY2017 | Jun 30, 2017 | $21.33M | – |
| Q1 FY2017 | Mar 31, 2017 | $18.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.91M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.29M | – |
See a number that looks wrong?